Cargando…

CSF GABA is reduced in first-episode psychosis and associates to symptom severity

Schizophrenia is characterized by a multiplicity of symptoms arising from almost all domains of mental function. γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain and is increasingly recognized to have a significant role in the pathophysiology of the disorder. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orhan, F, Fatouros-Bergman, H, Goiny, M, Malmqvist, A, Piehl, F, Cervenka, S, Collste, K, Victorsson, P, Sellgren, C M, Flyckt, L, Erhardt, S, Engberg, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984082/ https://www.ncbi.nlm.nih.gov/pubmed/28289277 http://dx.doi.org/10.1038/mp.2017.25

Ejemplares similares

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Becklén, Meneca, et al.
Publicado: (2021)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Lee, Maria, et al.
Publicado: (2021)

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
por: Xu, Chengai, et al.
Publicado: (2020)

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
por: Plavén-Sigray, Pontus, et al.
Publicado: (2021)

Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms()
por: Larsson, Cornelia, et al.
Publicado: (2022)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Theorell, Jakob, et al.
Publicado: (2021)

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
por: Shang, Pei, et al.
Publicado: (2022)

M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
por: Victorsson, Pauliina, et al.
Publicado: (2020)

GRK3 deficiency elicits brain immune activation and psychosis
por: Sellgren, Carl M., et al.
Publicado: (2021)

Correction: GRK3 deficiency elicits brain immune activation and psychosis
por: Sellgren, Carl M., et al.
Publicado: (2021)

Chronic Antipsychotic Treatment in the Rat – Effects on Brain Interleukin-8 and Kynurenic Acid
por: Larsson, Markus K, et al.
Publicado: (2015)

Determinants of subjective and objective burden of informal caregiving of patients with psychotic disorders
por: Flyckt, Lena, et al.
Publicado: (2015)

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
por: Gracias, Jessica, et al.
Publicado: (2022)

First episode psychosis: the depressive symptoms and suicidal behaviour that follow
por: Mesquita, B. L. B., et al.
Publicado: (2023)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

Identifying persistent negative symptoms in first episode psychosis
por: Hovington, Cindy L, et al.
Publicado: (2012)

A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis
por: Overbeek, Gregory, et al.
Publicado: (2021)

The effect of the environment on symptom dimensions in the first episode of psychosis: a multilevel study
por: Oher, F. J., et al.
Publicado: (2014)

Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
por: Modinos, Gemma, et al.
Publicado: (2017)

Linking persistent negative symptoms to amygdala–hippocampus structure in first-episode psychosis
por: Makowski, C, et al.
Publicado: (2017)

F186. TAPETUM ABNORMALITIES IN FIRST-EPISODE PSYCHOSIS AND RELATIONSHIP TO SYMPTOM SEVERITY AND DURATION OF UNTREATED PSYCHOSIS
por: Lee, Sun Woo, et al.
Publicado: (2018)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Extrapyramidal symptoms predict cognitive performance after first-episode psychosis
por: Lindgren, Maija, et al.
Publicado: (2022)

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
por: Ottesen, Akiah, et al.
Publicado: (2023)

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
por: Sellgren, CM, et al.
Publicado: (2013)

Association between duration of Untreated Psychosis and severer symptoms and poorer quality of life: study in First-Episode Psychosis patients
por: Pires, A. C. M., et al.
Publicado: (2023)

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
por: Huang, Jeffrey T.-J., et al.
Publicado: (2007)

First episode psychosis related to COVID-19 infection
por: Dhakouani, S., et al.
Publicado: (2022)

Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls
por: Sellgren, Carl M., et al.
Publicado: (2019)

White-matter hyperintensities in first-episode psychosis
por: Zanetti, Marcus V., et al.
Publicado: (2008)

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
por: Sellgren, C M, et al.
Publicado: (2016)

Can cognitive insight predict symptom remission in a first episode psychosis cohort?
por: O’Connor, Jennifer A., et al.
Publicado: (2017)

A patient with epileptic psychosis who had rare acute episodic symptoms()
por: Horinouchi, Toru, et al.
Publicado: (2014)

T123. PERSISTENT NEGATIVE SYMPTOMS IN FIRST EPISODE PSYCHOSIS: PREVALENCE, PREDICTORS AND PROGNOSIS
por: Austin, Stephen, et al.
Publicado: (2018)

Structure and stability of symptoms in first episode psychosis: a longitudinal network approach
por: Griffiths, Siân Lowri, et al.
Publicado: (2021)

Structural abnormalities of choroid vasculature in first-episode psychosis
por: Demirlek, C., et al.
Publicado: (2023)

Reinforcement and Reversal Learning in First-Episode Psychosis
por: Murray, G. K., et al.
Publicado: (2008)

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
por: Bergman, Petra, et al.
Publicado: (2016)

Symptoms of psychosis, depression, and suicide ideation among individuals in a first episode of psychosis: The mechanistic role of clinical insight and cognitive functioning
por: Bornheimer, L., et al.
Publicado: (2021)

Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis
por: Modinos, Gemma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3hg20pakhha6u214farqqfhdog